- Home
- OTLK vs SIF Comparison
OTLK vs SIF Comparison
Compare OTLK & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- SIF
- Stock Information
- Founded
- OTLK 2010
- SIF 1913
- Country
- OTLK United States
- SIF United States
- Employees
- OTLK N/A
- SIF N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- SIF Office Equipment/Supplies/Services
- Sector
- OTLK Health Care
- SIF Industrials
- Exchange
- OTLK Nasdaq
- SIF Nasdaq
- Market Cap
- OTLK 42.8M
- SIF 44.2M
- IPO Year
- OTLK 2016
- SIF N/A
- Fundamental
- Price
- OTLK $1.46
- SIF N/A
- Analyst Decision
- OTLK Buy
- SIF
- Analyst Count
- OTLK 5
- SIF 0
- Target Price
- OTLK $5.25
- SIF N/A
- AVG Volume (30 Days)
- OTLK 2.5M
- SIF 19.3K
- Earning Date
- OTLK 08-14-2025
- SIF 08-14-2025
- Dividend Yield
- OTLK N/A
- SIF N/A
- EPS Growth
- OTLK N/A
- SIF N/A
- EPS
- OTLK N/A
- SIF N/A
- Revenue
- OTLK $1,505,322.00
- SIF $83,663,000.00
- Revenue This Year
- OTLK N/A
- SIF N/A
- Revenue Next Year
- OTLK $313.69
- SIF N/A
- P/E Ratio
- OTLK N/A
- SIF N/A
- Revenue Growth
- OTLK N/A
- SIF 35.71
- 52 Week Low
- OTLK $0.79
- SIF $2.33
- 52 Week High
- OTLK $6.98
- SIF $7.88
- Technical
- Relative Strength Index (RSI)
- OTLK 62.88
- SIF 60.05
- Support Level
- OTLK $1.18
- SIF $6.85
- Resistance Level
- OTLK $1.30
- SIF $7.52
- Average True Range (ATR)
- OTLK 0.10
- SIF 0.29
- MACD
- OTLK 0.07
- SIF -0.01
- Stochastic Oscillator
- OTLK 83.63
- SIF 94.12
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About SIF SIFCO Industries Inc.
SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.